Literature DB >> 7251133

Evidence for two mechanisms of dengue virus infection of adherent human monocytes: trypsin-sensitive virus receptors and trypsin-resistant immune complex receptors.

C C Daughaday, W E Brandt, J M McCown, P K Russell.   

Abstract

Trypsin treatment of adherent human monocytes greatly reduced or eliminated the ability of these cells to support dengue virus replication. However, addition of dilute (nonneutralizing) antibody to the inoculum and the culture medium resulted in viral yields similar to those from monocytes not treated with trypsin. These results suggested that viral entry was facilitated by phagocytosis of immune complexes via Fc receptors on the monocytes. This concept was tested by (i) pretreating monocytes with aggregated gamma globulin, which resulted in a 40-fold reduction of viral yields after infection with dilute antibody-virus complexes and (ii) forming an immune complex with virus, antivirus F(ab')2 fragments, and rabbit anti-human Fab. Whereas F(ab')2 fragments alone would not enhance virus replication in trypsin-treated monocytes, the immune complex containing a rabbit Fc piece did increase the yield of dengue virus. These results suggest that dengue virus can infect a cultured monocyte in two ways: (i) through a viral receptor that is trypsin sensitive or (ii) through an Fc receptor that is not trypsin sensitive.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7251133      PMCID: PMC351468          DOI: 10.1128/iai.32.2.469-473.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

2.  Human monocytes: distinct receptor sites for the third component of complement and for immunoglobulin G.

Authors:  H Huber; M J Polley; W D Linscott; H H Fudenberg; H J Müller-Eberhard
Journal:  Science       Date:  1968-12-13       Impact factor: 47.728

3.  The macrophage receptor for IgG: number and affinity of binding sites.

Authors:  W P Arend; M Mannik
Journal:  J Immunol       Date:  1973-06       Impact factor: 5.422

4.  A method for preparing IgG F(ab')2 fragments using small amounts of serum.

Authors:  L H Madsen; L S Rodkey
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

5.  Antibody-enhanced dengue virus infection in primate leukocytes.

Authors:  S B Halstead; E J O'Rourke
Journal:  Nature       Date:  1977-02-24       Impact factor: 49.962

6.  Studies on the mechanism of heat aggregation of human gamma-G.

Authors:  W Augener; H M Grey
Journal:  J Immunol       Date:  1970-10       Impact factor: 5.422

7.  The aggregation of gamma-myeloma proteins.

Authors:  J H Morse
Journal:  J Immunol       Date:  1965-10       Impact factor: 5.422

8.  Receptor sites on human monocytes for complement: binding of red cells sensitized by cold autoantibodies.

Authors:  H Huber; S D Douglas
Journal:  Br J Haematol       Date:  1970-07       Impact factor: 6.998

9.  Dengue virus replication enhancement in peripheral blood leukocytes from immune human beings.

Authors:  S B Halstead; N J Marchette; J S Sung Chow; S Lolekha
Journal:  Proc Soc Exp Biol Med       Date:  1976-01

10.  In vitro adherence of soluble immune complexes to macrophages.

Authors:  W P Arend; M Mannik
Journal:  J Exp Med       Date:  1972-09-01       Impact factor: 14.307

View more
  39 in total

1.  Legionella pneumophila entry gene rtxA is involved in virulence.

Authors:  S L Cirillo; L E Bermudez; S H El-Etr; G E Duhamel; J D Cirillo
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

2.  Infection of human cells by dengue virus is modulated by different cell types and viral strains.

Authors:  M S Diamond; D Edgil; T G Roberts; B Lu; E Harris
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

Review 3.  Barriers to preclinical investigations of anti-dengue immunity and dengue pathogenesis.

Authors:  Ashley L St John; Soman N Abraham; Duane J Gubler
Journal:  Nat Rev Microbiol       Date:  2013-05-08       Impact factor: 60.633

4.  Characterization of dengue virus 2 growth in megakaryocyte-erythrocyte progenitor cells.

Authors:  Kristina B Clark; Hui-Mien Hsiao; Leda Bassit; James E Crowe; Raymond F Schinazi; Guey Chuen Perng; Francois Villinger
Journal:  Virology       Date:  2016-04-06       Impact factor: 3.616

5.  PrM- and cell-binding domains of the dengue virus E protein.

Authors:  S Wang; R He; R Anderson
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

6.  Identification of two surface proteins from C6/36 cells that bind dengue type 4 virus.

Authors:  J S Salas-Benito; R M del Angel
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

7.  Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes.

Authors:  R Anderson; S Wang; C Osiowy; A C Issekutz
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

8.  Characterization with monoclonal antibodies of human lymphocytes active in natural killing and antibody-dependent cell-mediated cytotoxicity of dengue virus-infected cells.

Authors:  I Kurane; D Hebblewaite; F A Ennis
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

9.  Antibody-mediated enhancement of parvovirus B19 uptake into endothelial cells mediated by a receptor for complement factor C1q.

Authors:  Kristina von Kietzell; Tanja Pozzuto; Regine Heilbronn; Tobias Grössl; Henry Fechner; Stefan Weger
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

10.  Lectin-mediated enhancement of dengue virus infection in a mouse macrophage cell line Mk1.

Authors:  H Hotta; M Homma
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.